Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    Antibiotic can affect INR levels

    Author:
    HT Staff
    Publish date: July 22, 2015

    Treatment with the antibiotic dicloxacillin may cause a significant decrease in international normalized ratio (INR) levels among patients taking...

    • Read More

    News

    Modified T cells may improve auto-SCT outcomes in MM

    Author:
    HT Staff
    Publish date: July 21, 2015

    Photo from Penn Medicine Infusions of modified autologous T cells may improve responses in multiple myeloma (MM) patients undergoing autologous...

    • Read More

    News

    Testosterone therapy doesn’t increase VTE risk

    Author:
    HT Staff
    Publish date: July 21, 2015

    for intramuscular injection Contrary to previous findings, a new study suggests there is no link between testosterone therapy and venous...

    • Read More

    News

    Response to ibrutinib varies by DLBCL subtype

    Author:
    HT Staff
    Publish date: July 21, 2015

    Photo by Larry Young Responses to the BTK inhibitor ibrutinib differ according to a patient’s subtype of diffuse large B-cell lymphoma (DLBCL),...

    • Read More

    News

    A new way to treat ITP?

    Author:
    HT Staff
    Publish date: July 20, 2015

    Photo courtesy of St. Michael’s Hospital New research appears to explain why symptoms and treatment responses vary in patients with immune...

    • Read More

    News

    Group creates mouse model of RUNX1-mutated AML

    Author:
    HT Staff
    Publish date: July 20, 2015

    Researchers have developed a mouse model to help them understand why patients with RUNX1-mutated acute myeloid leukemia (AML) respond poorly to...

    • Read More

    News

    FDA approves patch for treating hemorrhage

    Author:
    HT Staff
    Publish date: July 19, 2015

    Image by James Weaver The US Food and Drug Administration (FDA) has granted 501(k) clearance for the Hemogrip Patch, a product used to treat...

    • Read More

    News

    Pegylated rFVIII product produces favorable results in hemophilia A

    Author:
    HT Staff
    Publish date: July 18, 2015

    An investigational recombinant factor VIII (rFVIII) product can safely treat and prevent bleeding in previously treated patients with hemophilia A...

    • Read More

    News

    Rivaroxaban safe, effective after ED admission

    Author:
    HT Staff
    Publish date: July 17, 2015

    Photo courtesy of the CDC Patients admitted to the emergency department (ED) for venous thromboembolism (VTE) can be placed on oral...

    • Read More

    News

    Polyphenols may enhance doxorubicin treatment

    Author:
    HT Staff
    Publish date: July 17, 2015

    Photo by Rhoda Baer New research suggests the polyphenols resveratrol and quercetin could be used to augment treatment with the anthracycline...

    • Read More

    News

    Mosquitoes can accumulate malaria infections

    Author:
    HT Staff
    Publish date: July 17, 2015

    Photo courtesy of the CDC Repeat infection with malaria parasites might make mosquitoes more dangerous, according to a study published in PLOS...

    • Read More

    News

    Arginine plays role in thalassemia complication

    Author:
    HT Staff
    Publish date: July 17, 2015

    Low bioavailability of the amino acid arginine may contribute to cardiopulmonary dysfunction in patients with β-thalassemia, according to...

    • Read More

    News

    New antimalarial progresses to clinical trials

    Author:
    HT Staff
    Publish date: July 16, 2015

    falciparum in a mouse liver Image courtesy of Seattle Biomedical Research Institute A new compound can fight multidrug-resistant malaria,...

    • Read More

    News

    IRB members and industry relationships

    Author:
    HT Staff
    Publish date: July 16, 2015

    Institutional Review Boards (IRBs) at academic health centers have gotten better at managing members’ industry relationships in the last several...

    • Read More

    News

    Drug granted orphan designation for MM

    Author:
    HT Staff
    Publish date: July 16, 2015

    The US Food and Drug Administration (FDA) has granted orphan designation for the drug CB-5083 to treat multiple myeloma (MM). CB-5083 works by...

    • Read More

    Pages

    • « first
    • …
    • 167
    • 168
    • 169
    • 170
    • 171
    • 172
    • 173
    • 174
    • 175
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery